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ABSTRACT  
Objective: A facile and efficient synthesis of new pyrazoloisoxazole, isoxazolopyridine and isoxazolopyrimidine derivatives is discribed through 
interaction of isoxazolone derivative with different nitrogen nucleophiles. Nine of the newly synthesized compounds were tested for antibacterial 
activities. 
Methods: Interaction of isoxazolone derivative with different nitrogen nucleophiles under grinding conditions.  
Results: New pyrazoloisoxazole, isoxazolopyridine and isoxazolopyrimidine derivatives were synthesized and the structures of the prepared 
compounds were elucidated from spectral data.  
Conclusion: 4-(4-Chlorobenzylidene)-3-phenylisoxazol-5(4H)-one was utilized as key intermediate for the synthesis of some new heterocycles, 
namely pyrazoloisoxazole, isoxazolopyridine and isoxazolopyrimidine derivatives under grinding conditions. Most of the newly synthesized 
products revealed moderate activity against Gram-negative and Gram-positive bacteria. 
Keywords: Isoxazolone derivative, Pyrazoloisoxazole derivatives, Hydrazino and hydrazides compounds, Grinding and antimicrobial activity. 
 
INTRODUCTION 
In a previous work we reported that some of our newly substituted 
heterocyclic compounds exhibited antitumor [1-4], antimicrobial [5-9] 
and 5-α-reductase inhibitors [10] activities. Pyrazoloisoxazole ring 
system presents interesting pharmacological and biological activities 
as chemotherapeutic agents, previous work showed the use of such 
compounds in treatment of Alzheimer's disease [11]. In addition, 
pyrazoloisoxazoles possess various biological activities including 
antimicrobial [12,13], herbicide [14], hence, pyrazoloisoxazoles have 
wide applications in pharmaceutical field as well as in agrochemical 
industry. Numerous compounds containing pyrazoloisoxazoles 
moieties have been shown to exhibit anti-hyperglycemic, analgesic, 
anti-inflammatory, antiviral, antitumor, antifungal and anti-depressant 
activities [15-27], they are also useful intermediate for many industrial 
products [28, 29].  In view of these reports and in continuation of our 
previous works in synthesis of bioactive heterocyclic compounds, we 
have herein interested in synthesis of novel pyrazoloisoxazoles and 
investigation their antibacterial activity. 
MATERIALS AND METHODS 
Melting points were measured on Electrothermal IA 9000 series 
digital melting point apparatus. The IR spectra were recorded in 
potassium bromide discs on a Pye Unicam SP 3300 and Shimadzu FT 
IR 8101 PC infrared spectrophotometer. 1H NMR spectra was recorded 
in deuterated dimethyl sulfoxide (DMSO-d6) using a Varian Gemini 
300 NMR spectrometer. Mass spectra were recorded on a Shimadzu 
GCMS-QP1000 EX mass spectrometer at 70 eV. Elemental analysis and 
antibacterial measurements were carried out at the Microanalytical 
Centre of Cairo University, Giza, Egypt. All reactions were followed by 
TLC (Silica gel, Merck). 4-(4-Chlorobenzylidene)-3-phenylisoxazol-
5(4H)-one [30] was prepared as reported in the literature. 
Synthesis of pyrazolo[4,3-d]isoxazoles 3a,b, 7, 9, 11 and 
isoxazolo[5,4-c]isoxazole 5  
General procedure 
A mixture of 4-(4-chlorobenzylidene)-3-phenylisoxazol-5(4H)-one 1 
(0.283 g, 1 mmol) and each of the appropriate hydrazine derivatives, 
namely hydrazinehydrate 2a, phenylhydrazine 2b, (2,6-dichloro-4-
(trifluoromethyl)phenyl)hydrazine 6, 2-hydrazinyl-4,4-diphenyl-1H-
imidazol-5(4H)-one 8, 3-hydrazinyl-5,6-diphenyl-1,2,4-triazine 10 
or hydroxylamine hydrochloride 4 (1 mmol) and few drops of acetic 
acid was thoroughly ground with a pestle in an open mortar at room 
temperature for 3-6 min until the mixture turned into a melt. The 
initial syrupy continued for 5-15 min and the reaction was 
monitored by TLC. The solid was washed with water and crystallized 
from the appropriate solvent to give pyrazolo[4,3-d]isoxazoles 3a,b, 
7, 9, 11 and isoxazolo[5,4-c]isoxazole 5, respectively. The 
synthesized compounds 3a,b, 5, 7, 9 and 11 together with their 
physical and spectral data are listed below. 
4-(4-Chlorophenyl)-3-phenyl-5,6-dihydro-4H-pyrazolo[4,3-
d]isoxazole (3a). Yield 72%; white solid; mp 238-240 oC; 1HNMR 
(DMSO-d6): δ 4.73 (s, 1H, Pyrazole-H), 7.21-7.87 (m, 9H, ArH), 8.60, 
11.23 (2s, 2H, D2O exchangeable, 2NH); IR (KBr): vmax 1636 (C=N), 3195, 
3336 (2NH) cm-1; MS m/z (%): 299(M++2, 5), 297(M+, 14), 282(31), 
160(59), 103(89), 51(100). Anal.Calcd for C16H12ClN3O (297.74): C, 
64.54; H, 4.06; N, 14.11. Found C, 64.59; H, 4.02; N, 14.04%. 
4-(4-Chlorophenyl)-3,5-diphenyl-5,6-dihydro-4H-pyrazolo[4,3-
d]isoxazole (3b). Yield 78%; white solid; mp 230-232 oC; 1HNMR 
(DMSO-d6): δ 4.77 (s, 1H, Pyrazole-H), 7.17-7.82 (m, 14H, ArH), 8.61 
(s, 1H, D2O exchangeable, NH); IR (KBr): vmax 1638 (C=N), 3332 (NH) 
cm-1; MS m/z (%): 375(M++2, 8), 373(M+, 26), 186(54), 147(42), 
130(87), 60(100). Anal. Calcd for C22H16ClN3O (373.83): C, 70.68; H, 
4.31; N, 11.24. Found C, 70.55; H, 4.25; N, 11.16%. 
4-(4-Chlorophenyl)-5-(2,6-dichloro-4-
(trifluoromethyl)phenyl)-3-phenyl-5,6-dihydro-4H-
pyrazolo[4,3-d]isoxazole (5). Yield 71%; white solid; mp 123-125 
oC; 1HNMR (DMSO-d6): δ 4.82 (s, 1H, Pyrazole-H), 7.11-7.84 (m, 11H, 
ArH), 8.63 (s, 1H, D2O exchangeable, NH); IR (KBr): vmax 1602 (C=N), 
3331 (NH) cm-1; MS m/z (%): 510(M+, 13), 343(43), 208(42), 
111(87), 75(100). Anal. Calcd for C23H13Cl3F3N3O (510.72): C, 54.09; 
H, 2.57; N, 8.23. Found C, 54.17; H, 2.50; N, 8.17%. 
2-(4-(4-Chlorophenyl)-3-phenyl-4H-pyrazolo[4,3-d]isoxazol-
5(6H)-yl)-4,4-diphenyl-1H-imidazol-5(4H)-one (7). Yield 78%; 
white solid; mp 322-324 oC; 1HNMR (DMSO-d6): δ 4.68 (s, 1H, 
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Pyrazole-H), 7.07-7.73 (m, 19H, ArH), 8.63 (s, 1H, D2O exchangeable, 
NH), 10.18 (s, 1H, D2O exchangeable, NH); IR (KBr): vmax 1606 (C=N), 
1645 (C=O), 3166, 3339 (2NH) cm-1; MS m/z (%): 533(M++2, 13), 
531(M+, 35), 357(64), 220(64), 152(63), 59(100). Anal. Calcd for 
C31H22ClN5O2 (531.99): C, 69.99; H, 4.17; N, 13.16. Found C, 69.91; H, 
4.12; N, 13.05%. 
4-(4-Chlorophenyl)-5-(5,6-diphenyl-1,2,4-triazin-3-yl)-3-
phenyl-5,6-dihydro-4H-pyrazolo [4,3-d]isoxazole (9). Yield 75%; 
yellow solid; mp 292-294 oC; 1HNMR (DMSO-d6): δ 4.66 (s, 1H, 
Pyrazole-H), 7.12-7.79 (m, 19H, ArH), 8.66 (s, 1H, D2O exchangeable, 
NH); IR (KBr): vmax 1600 (C=N), 3332 (NH) cm-1; MS m/z (%): 
530(M++2, 6), 528(M+, 17), 499(76), 306(84), 105(89), 77(100). 
Anal. Calcd for C31H21ClN6O (528.99): C, 70.39; H, 4.00; N, 15.89. 
Found C, 70.26; H, 4.04; N, 15.77%. 
4-(4-Chlorophenyl)-3-phenyl-4,6-dihydroisoxazolo[5,4-
c]isoxazole (11) 
Yield 78%; yellow solid; mp 195-196 oC; 1HNMR (DMSO-d6): δ 4.83 
(s, 1H, isoxazole-H), 7.22-7.69 (m, 9H, ArH), 9.19 (s, 1H, D2O 
exchangeable, NH); IR (KBr): vmax 1614 (C=N), 3348 (NH) cm-1; MS 
m/z (%): 300(M++2, 45), 298(M+, 37), 238(76), 189(59), 80(100). 
Anal. Calcd for C16H11ClN2O2 (298.72): C, 64.33; H, 3.71; N, 9.38. 
Found C, 64.27; H, 3.56; N, 9.23%. 
Reaction of arylidene 1 with acid hydrazides 12, 14 and 16  
A mixture of 1 (0.283 g, 1 mmol) and each of benzohydrazide 12, 
benzenesulfonohydrazide 14 or terephthalohydrazide 16 (1 mmol) 
and few drops of acetic acid was thoroughly ground with a pestle in 
an open mortar at room temperature for 3-6 min until the mixture 
turned into a melt and grinding was continued for further 5-15 min 
(monitored by TLC).  
The solid formed was washed with water and crystallized from the 
appropriate solvent to give pyrazolo[4,3-d]isoxazole 13, 15 and 
bispyrazolo[4,3-d]isoxazole 17 derivatives, respectively.  
(4-(4-Chlorophenyl)-3-phenyl-4H-pyrazolo[4,3-d]isoxazol-
5(6H)-yl)(phenyl)methanone (13). Yield 69%; white solid; mp 
183-185 oC; 1HNMR (DMSO-d6): δ 4.68 (s, 1H, Pyrazole-H), 7.16-7.94 
(m, 14H, ArH), 8.72 (s, 1H, D2O exchangeable, NH); IR (KBr): vmax 
1598 (C=N), 1651 (C=O), 3329 (NH) cm-1; MS m/z (%): 403(M++2, 
17), 401(M+, 46), 317(64), 234(78), 109(75), 53(100). Anal. Calcd 
for C23H16ClN3O2 (401.85): C, 68.74; H, 4.01; N, 10.46. Found C, 68.64; 
H, 4.00; N, 10.32%. 
4-(4-Chlorophenyl)-3-phenyl-5-(phenylsulfonyl)-5,6-dihydro-
4H-pyrazolo[4,3-d]isoxazole 
(15). Yield 74%; white solid; mp 146-148 oC; 1HNMR (DMSO-d6): δ 
4.86 (s, 1H, Pyrazole-H), 7.23-7.90 (m, 14H, ArH), 9.32 (s, 1H, D2O 
exchangeable, NH); IR (KBr): vmax 1594 (C=N), 3303 (NH) cm-1; MS 
m/z (%): 439(M++2, 33), 437(M+, 86), 321(54), 222(69), 124(82), 
89(100). Anal. Calcd for C22H16ClN3O3S (437.90): C, 60.34; H, 3.68; N, 
9.60. Found C, 60.17; H, 3.61; N, 9.39%. 
1,4-Phenylenebis((4-(4-chlorophenyl)-3-phenyl-4H-
pyrazolo[4,3-d]isoxazol-5(6H)-yl) methanone) (17). Yield 63%; 
white solid; mp 342-344 oC; 1HNMR (DMSO-d6): δ 4.63 (s, 2H, 
2Pyrazole-H), 7.19-7.64 (m, 14H, ArH), 7.86 (s, 8H, ArH), 8.78 (s, 2H, 
D2O exchangeable, 2NH); IR (KBr): vmax 1599 (C=N), 1647 (C=O), 
3324 (NH) cm-1; MS m/z (%): 726(M++2, 46), 724(M+, 88), 594(100), 
487(90), 357(72), 148(81), 73(83). Anal. Calcd for C40H26Cl2N6O4 
(725.58): C, 66.21; H, 3.61; N, 11.58. Found C, 66.05; H, 3.54; N, 
11.44%. 
Synthesis of 4-(4-chlorophenyl)-3-phenyl-4,10-dihydrobenzo 
[b] isoxazolo[5,4-e][1,4] thiazepine (19). A mixture 1 (0.283 g, 1 
mmol), 2-aminobenzenethiol 18 (0.125 g, 1 mmol) and few drops of 
acetic acid was thoroughly ground with a pestle in an open mortar at 
room temperature for 3 min until the mixture turned into a melt. 
The initial syrupy continued for 15 min. The solid was washed with 
water and crystallized from DMF to give 19 in 66 % yield as yellow 
solid; mp 112-114 °C; 1HNMR (DMSO-d6): δ 4.81 (s, 1H, Pyrazole-H), 
7.20-7.78 (m, 13H, ArH), 12.26 (s, 1H, D2O exchangeable, NH); IR 
(KBr): vmax 1590 (C=N), 3422 (NH) cm-1; MS m/z (%): 392(M++1, 7), 
390(M+, 69), 301(74), 208(67), 130(100), 66(74). Anal. Calcd for 
C22H15ClN2OS (390.89): C, 67.60; H, 3.87; N, 7.17. Found C, 67.46; H, 
3.77; N, 7.03%. 
Synthesis of 5-acetyl-4-(4-chlorophenyl)-3,7-diphenylisoxazolo 
[5,4-b]pyridin-6(7H)-one (21).A mixture 1 (0.283 g, 1 mmol), 
acetoacetanilide 20 (0.177 g, 1 mmol), and potassium carbonate (0.3 
g) was thoroughly ground with a pestle in an open mortar at room 
temperature for 4 min until the mixture turned into a melt. The 
initial syrupy continued for 15 min. The solid was washed with 
water and crystallized from DMF to give 21 in 72 % yield as yellow 
solid; mp 250-252°C; 1HNMR (DMSO-d6): δ 2.48 (s, 3H, CH3CO), 7.12-
7.87 (m, 14H, ArH); IR (KBr): vmax 1599 (C=N), 1705, 1647 (2C=O), 
3323 (NH) cm-1; MS m/z (%): 442(M++2, 16), 440(M+, 50), 325(56), 
183(83), 80(57), 64(100). Anal. Calcd for C26H17ClN2O3 (440.88): C, 
70.83; H, 3.89; N, 6.35. Found C, 70.69; H, 3.91; N, 6.28%. 
Agar diffusion well method to determine the antimicrobial 
activity: The microorganism inoculums were uniformly spread 
using sterile cotton swabs on a sterile Petri dish containing nutrient 
agar. One hundred cubic millimeters of each sample was added to 
each well (10-mm-diameter holes were cut in the agar gel). The 
systems were incubated for 24–48 h at 37 0C. After incubation, the 
microorganism growth was observed. Inhibition zones of the 
bacterial growth were measured in millimeters. Tests were 
performed in triplicate [31]. 
RESULTS AND DISCUSSION 
Our synthetic strategy is based on the reaction of the key 
intermediate isoxazolone derivative 1(easily prepared from ethyl 
benzoylacetate, hydroxyl amine hydrochloride and aromatic 
aldehyde as depicted in literature [30]) with different nucleophilic 
reagents. The carbonyl group in combination with the arylidene 
double bond, provide a rich opportunity for heterocyclic 
construction. Herein, the carbonyl oxygen could be removed as a 
molecule of water with hydrogens bearing compounds and the 
arylidene double bond could disappear through Michael-like type 
addition; synthetic strategy successfully provides a concise one-pot 
reaction to afford the target compounds in fairly good yields. In a 
first experiment, The reaction of compound 1 with different nitrogen 
nucleophiles such as hydrazine and phenylhydrazine simply 
furnished the pyrazoloisoxazole derivative 3a,b (scheme 1). The 
reaction was performed through grinding at room temperature 
without addition of any solvent. The structures of the synthesized 
compounds were established on the basis of IR, 1HNMR, elemental 
analysis and molecular weights of them were confirmed by mass 
spectrometry. The IR spectrum of compound 3a revealed absorption 
bands in the range of 3195-3336 due to the NH stretching vibrations 
while the absorption bands of the carbonyl and the arylidene double 
bond functipns have been disappeared, Furthermore, the mass 
spectra for compound 3a,b showed the correct molecular ion peaks 
consistent with the proposed structures. In the 1HNMR spectrum of 
compound 3a, very characteristic signal at 4.73 ppm attributed to 
the benzylic proton in the pyrazole ring, in addition, two 
exchangeable protons signals at 8.60 and 11.23 ppm due to the two 
NH functions. The simplicity and effeciency of such reactions, forced 
us to investigate the combination of title compound 1 with more 
versatile hydrazino compounds, 2,6-dichloro-4-trifluoromethyl-
phenyl hydrazine 4 reacted in the same manner with compound 1 
under same conditions to afford compound 5. In addition, the 
isoxazolone derivative 1 reacted with hydrazinohydantoin 6 and 
hydrazinotriazine 8 under same conditions to give the 
corresponding pyrazoloisoxazole derivatives 7 and 9 respectively 
(scheme 1). The structures of compounds 5, 7 and 9 were elucidated 
based on their elemental analysis and spectral data, IR spectra of all 
compounds displayed absorption bands in the range 3331-3339 cm-
1due to NH functions, in addition an absorption band in the 
spectrum of compound 7 at 1645 cm-1 assigned to the hydantoin 
carbonyl group. The mass spectra of compounds 5 and 7 showed the 
correct molecular ion peaks at m/e = 510 and m/e = 531 
respectively. However, the 1HNMR spectrum of compound 9 gave a 
signal at 4.66 ppm characteristic to benzylic proton (pyrazole ring), 
also, the aromatic region displayed signals in the range 7.12-7.79 
ppm integrating for 19 protons (in comparison with 9 protons in the 
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starting material), a downfield one exchangeable proton signal at 
8.66 ppm related to the NH group. On the other hand, the 
combination between compound 1 and hydroxylamine 
hydrochloride under grinding proceeded in the same manner but 
furnished the isoxazoloisoxazole derivative 11 in a very good yield 
(scheme 1). Structure confirmations of compound 11 were assisted 
from its IR mass spectrum and elemental analysis. 
 
Scheme 1: Reaction of 1 with hydrazines and hydroxylamine 
 
Scheme 2: Reaction of 1 with acid hydrazides 12, 14 and bis-
hydrazides 16 
Furthermore, the high reactivity of the isoxazolone 1 towards nitrogen 
nucleophiles was also appeared from its reaction with hydrazides 
represented in compounds 12, 14 and 16 (two equivalents of 1 were 
used as 16 contained two hydrazide functions) which all reacted 
under same conditions to afford compounds 13, 15 and 17 
respectively (scheme 2). The presence of the carbonyl group in the 
hydrazide structure doesn’t affect the reactivity of the NH group so 
much except the yields were not so good. The structures of these 
products were assisted from their elemental analysis and spectral 
data, The IR of all displayed strong absorption bands from 3303 to 
3329 cm-1 attributable to NH groups, compounds 13 and 17 showed 
absorption bands at 1651 and 1647 cm-1 respectively related to the 
amide carbonyl groups. The mass spectrum for example for compound 
13 revealed a molecular ion peak at m/e = 401 consistent with 
proposed structure, in the 1HNMR spectrum of compound 15 a singlet 
signal at 4.86 ppm assigned to benzylic proton (pyrazole ring), the 
aromatic region at 7.23-7.90 ppm integrating for 14 protons and a 
downfield signal at 9.32 ppm (NH proton). 
2-Aminothiophenol as a bifunctional group compound possesing a 
nucleophilic sulfur atom which can add to the arylidene double bond 
of the isoxazolone 1 in a Michael-like type protocol; the amino 
function can add to the isoxazolone cabonyl group followed by loss 
of a molecule of water furnishing at the end the tricyclic 
isoxazolobenzothiazepine 19.  
The IR spectrum of compound 19 is devoid from absorption bands 
in the carbonyl region, in addition an absorption band at 2945 cm-
1 due to CH aliphatic and NH stretching vibration appeared at 
3354 cm-1. The EI mass spectrum showed the correct molecular 
ion peak at m/e = 391. 
Finally, Pyridines such as compound 21 were obtainable from the 
isoxazolone 1 when combined with acetoacetanilide 20 in alcohol 
and NaOH at room temperature (scheme 3); the reaction 
proceeded through addition of the methylene group in compound 
20 to the arylidene double bond in compound 1 followed by 
tautomerization to the enol form which underwent water removal 
to give the product 21. 
 The IR spectrum of compound 21 showed two characteristic bands 
at 1705 and 1647 cm-1 attributable to the acetyl and cyclic carbonyl 
groups, in its 1HNMR spectrum, a singlet signal at 2.48 ppm assigned 
to methyl protons, also aromatic region enriched with additional five 
protons. 
 
Scheme 3: Reaction of 1 with compounds 18 and 20 
Antimicrobial evaluation 
The antibacterial activity of the newly synthesized compounds (3a, 
3b, 5, 7, 9, 11, 13, 15 and 17) was evaluated in vitro against 
Staphylococcus aureus (SA, RCMB 000106) and Bacillis subtilis (BS, 
RCMB 000107) as examples of Gram-positive bacteria and 
Pseudomonas aeruginosa (PA, RCMB 000102) and Escherichia coli 
(EC, RCMB 000103) as examples of Gram-negative bacteria. The 
inhibition zone diameter (IZD) in millimeters was used as a criterion 
for the antimicrobial activity using the agar diffusion method. 
Streptomycin was used as reference to evaluate the potency of the 
tested compounds under the same conditions. The results are 
depicted in Tables 1. 
The results revealed that most of the tested compounds displayed 
variable inhibitory effects on the growth of the tested Gram-positive 
bacteria and Gram-negative bacteria strains.  
In general, most of the tested compounds revealed better activity 
against the Gram-positive bacteria than against the Gram-negative 
bacteria. Compounds 5 and 15 have high inhibition effects against 
the four bacteria strains due to presence of fluorine or sulphone 
moieties. 
Compounds 3a, 3b, 13 and 17 exhibited no activity against PA while 
compounds 3b, 9 and 13 exhibited no activity against SA. 
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Table 1: Antibacterial activity of the tested compounds 
Sample number 
 
Inhibition zone diameter (mm / mg sample) 
Gram-positive Bacteria Gram-negative Bacteria  
S. aureus B. subtilis E. coli P. aeruginosa 
3a 11 14 13 - 
3b - 11 - - 
5 20 26 23 21 
7 19 22 21 22 
9 - 16 18 15 
11 17 15 18 14 
13 - 11 13 - 
15 23 26 20 24 
17 12 14 - - 
Streptomycin 25 29 24 25 
(-) No inhibition zone 
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